A case of insulinoma with non-alcoholic fatty liver disease: Roles of hyperphagia and hyperinsulinemia in pathogenesis of the disease

Endocrine Journal

Volumn 62, Issue 11, 2015, Pages 1025-1030

  Rokutan, Mariyo ^a,c   Yabe, Daisuke ^a,b   Komoto, Izumi ^a   Kurose, Takeshi ^a   Kawai, Jun ^a   Nakamura, Takefumi ^a   Imamura, Masayuki ^a   Seino, Yutaka ^a  

^a KANSAI ELECTRIC POWER CO   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Fibroscan; Fructose; Insulinoma; Non alcoholic fatty liver disease

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FRUCTOSE; LIVER ENZYME; TRIACYLGLYCEROL;

ADULT; CANCER SURGERY; CASE REPORT; FRUIT; HOSPITAL ADMISSION; HUMAN; HYPERINSULINEMIA; HYPERPHAGIA; HYPOGLYCEMIA; INSULINOMA; MALE; NONALCOHOLIC FATTY LIVER; NOTE; OVERNUTRITION; PATHOGENESIS; WEIGHT REDUCTION; COMPLICATION; HYPERINSULINISM; NON-ALCOHOLIC FATTY LIVER DISEASE; PANCREAS TUMOR; PATHOLOGY;

ADULT; HUMANS; HYPERINSULINISM; HYPERPHAGIA; INSULINOMA; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; PANCREATIC NEOPLASMS;

EID: 84948975583     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ14-0590     Document Type: Note

References (10)

1. Chalasani N, Younossi Z, Lavine JE, Dieahl AM, Brunt EM, et al. (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Am J Gastroenterol 107: 811-826.
2. Vuppalanchi R, Chalasani N (2009) Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management. Hepatology 49: 306-317.
3. Imamura M (2010) Recent standardization of treatment strategy for pancreatic neuroendocrine tumors. World J Gastroenterol 16: 4519-4525.
4. Morin E, Cheng S, Mete O, Serra T, Araujo PB, et al. (2013) Hormone profiling, WHO 2010 grading, and AJCC/UICC staging in pancreatic neuroendocrine tumor behavior. Cancer Med 2: 701-711.
5. Rindi G, Arnold R, Bosman FT, Capella C, Klimstra DS et al. (2010) Nomenclature and classification of neuroendocrine neoplasms of the digestive system. In: Bosman FT, Carneiro F, Hruban RH, Theise ND (eds). WHO classification of tumors of the digestive system (4th). International Agency for Research on Cancer, Lyon: 13-14.
6. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, et al. (1999) Nonalcoholic fatty liver disease; a spectrum of clinical and patholigical severity. Gastroenterol 116: 1413-1419.
7. Karlas T, Petroff D, Garnov N, Böhm S, Tenckhoff H, et al. (2014) Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy. PLoS One 9: e91987.
8. Johnson RJ, Nakagawa T, Sanchez-Lozada LG, Shafiu M, Sundaram S, et al. (2013) Sugar, Uric acid, and the Etiology and Obesity. Diabetes 62: 3307-3315.
9. Kanerva N, Sandboge S, Kaartinen NE, Männnistö S, Eriksson JG (2014) Higher fructose intake is inversely associated with risk of nonalcoholic fatty liver disease in older Finnish adults. Am J Clin Nutr 100: 1133-1138.
10. Kim HJ, Kim HJ, Lee KE, Kim DJ, Kim SK, et al. (2004) Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch Intern Med 164: 2169-2175.